Los Altos Hills, CA, United States of America

Snezana Drmanac

This inventor holds 32 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in DNA Sequencing. Top assignees: Complete Genomics, Inc., Callida Genomics, Inc., Mgi Tech Co., Ltd.. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Snezana Drmanac. Retrieved from https://idiyas.com/inventor/snezana-drmanac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 21)

% Patents Active = 90.6

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 4.6

ph-index = 13

Forward Citations = 1,226(Granted Patents)

Location History:

Palo Alto, CA (US) (2001 - 2011)
Guangdong, CN (2021)
Shenzhen, CN (2021)
Los Altos Hills, CA (US) (2012 - 2023)

Company Filing History:

10 out of 80

Complete Genomics, Inc.

patents

9 out of 25

Callida Genomics, Inc.

7. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

DNA Sequencing

Nucleic Acid Sequencing

Controlled Strand Displacement

High Throughput

Single Molecule Arrays

DNA Polymerase

Affinity Reagents

Genetic Analysis

Three Dimensional Arrays

Signal Confinement Sequencing

Reversibly Blocked Nucleoside Analogues

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655481 - DNA SEQUENCING USING CONTROLLED STRAND DISPLACEMENT (2026-06-16),

2. 12331354 - DNA array (2025-06-17),

3. 12331353 - DNA concatemers on a surface (2025-06-17),

4. 12195493 - Reversibly blocked nucleoside analogues and their use (2025-01-14),

5. 11788138 - Nucleic acid sequencing using affinity reagents (2023-10-17),

6. 11761040 - DNA protection agent in DNA imaging buffer (2023-09-19),

7. 11319588 - DNA sequencing using controlled strand displacement (2022-05-03),

8. 10988501 - Reversibly blocked nucleoside analogues and their use (2021-04-27),

9. 10961519 - PHi29 DNA polymerase mutant with increased thermostability (2021-03-30),

10. 10883092 - Phi29 DNA polymerase and encoding gene and application thereof (2021-01-05),

11. 10883091 - DNA polymerase variant and application thereof (2021-01-05),

12. 10851410 - Nucleic acid sequencing using affinity reagents (2020-12-01),

13. 10351909 - DNA sequencing from high density DNA arrays using asynchronous reactions (2019-07-16),

14. 10227647 - DNA sequencing using controlled strand displacement (2019-03-12),

15. 10190162 - Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing (2019-01-29),

Title: Snezana Drmanac - Pioneer in Biotechnology

Introduction: Snezana Drmanac is a renowned inventor based in Los Altos Hills, CA, known for her groundbreaking work in the field of biotechnology.

Latest Patents: Snezana Drmanac holds several patents related to DNA sequencing technologies, including a recent patent for a novel method of high-throughput sequencing of genetic material.

Career Highlights: With a career spanning over two decades, Drmanac has made significant contributions to the development of next-generation sequencing platforms, revolutionizing the way genetic information is analyzed and utilized in various industries.

Collaborations: Throughout her career, Snezana Drmanac has collaborated with leading research institutions, biotech companies, and academic organizations to further advance the field of genomics and personalized medicine.

Conclusion: Snezana Drmanac's innovative spirit and dedication to advancing biotechnology have solidified her reputation as a trailblazer in the field, with her work continuing to shape the future of genetic research and healthcare.

Profile summary based on public USPTO records.